Our Evidence
These studies show the impact and potential for host response diagnostics.
Host Response diagnostics have immense potential to save human lives and combat antimicrobial resistance by providing quick and predictive diagnoses. With its remarkable accuracy and efficiency, it could very well revolutionize global healthcare while also mitigating the effects of future pandemics.
We are hard at work to define and advance the full capabilities of host response diagnostics, but there is already a strong body of evidence of just how impactful this technology will be.
The Evidence of Host Response Effectiveness
In 2021, Biomeme merged with Predigen, a spin-out from Duke University and a global leader in the development of host gene expression signatures for use as prognostic, diagnostic, and therapeutic monitoring tools. That merger was made with the intention of advancing host response diagnostics by combining Predigen's machine learning algorithms with Biomeme's portable molecular testing platform.
The mission of these two companies is trusted by some of the world's most respected organizations, such as Cross-Border Threat Screening, National Institutes of Health, and the Antibacterial Resistance Leadership Group, and heavily featured in highly trusted publications such as DHS Science and Technology.
But don't take our word for it; read these studies to see the potential impact of Biomeme's host response technology on the advancement of global health.
Selected Host Response Studies
23 peer-reviewed publications spanning over a decade of host response research.
The host transcriptional response to Candidemia is dominated by neutrophil activation and heme biosynthesis and supports novel diagnostic approaches.
View on PubMed March 2021A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study.
View on PubMed Feb 2021Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
View on PubMed Jan 2021Validation of a host gene expression test for bacterial/viral discrimination in immunocompromised hosts.
View on PubMed July 2020Previously derived host gene expression classifiers identify bacterial and viral etiologies of acute febrile respiratory illness in a south Asian population.
View on PubMed Oct 2019Validation of a host response test to distinguish bacterial and viral respiratory infection.
View on PubMed Aug 2019Epithelial and airway secretion host response distinguishes bacterial and viral infections.
View on PubMed April 2019Host gene expression classifiers diagnose acute respiratory illness etiology.
View on PubMed Oct 2018Improved detection of bacterial and viral coinfection using host gene expression classification.
View on PubMed March 2018Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters.
View on PubMed Feb 2018A community approach to mortality prediction in sepsis via gene expression analysis.
View on PubMed Dec 2017A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.
View on PubMed March 2017Performance of a host response gene expression classifier for detection of bacterial and viral infection in febrile children.
View on PubMed July 2016Host gene expression signatures for discriminating clinical outcomes of severe trauma: a multicenter study.
View on PubMed Oct 2015A community-based host gene expression analysis for diagnosis of respiratory viral vs. bacterial infection.
View on PubMed March 2016A genomic signature of influenza infection shows potential for presymptomatic detection, guiding early therapy, and monitoring clinical responses.
View on PubMed Jan 2016Transcriptomic analysis of the host response and innate resilience to Enterotoxigenic Escherichia coli infection in humans.
View on PubMed Dec 2015Potential cost-effectiveness of early identification of hospital-acquired infection in critically ill patients.
View on PubMed Sep 2013Broad range host response gene expression classifiers identify infecting organisms in humans.
View on PubMed Jan 2013Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans.
View on PubMed Aug 2011A genomic signature to rapidly identify influenza and differentiate from other respiratory infections.
View on PubMed Jul 2010Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.
View on PubMed Sep 2009Classification of acute respiratory viral infections by host gene expression signatures.
View on PubMed*Biomeme's HR-B/V Test is currently under development and is not approved/cleared by the FDA.
Body Language Decoded
Learn more about Biomeme's Host Response Test (HR-B/V).